Microscopic cells race to victory in first World Cell Race at ASCB meeting
December 3, 2011 in CancerA "team" of fast-moving, bone marrow stem cells from a research laboratory in Singapore has run away with the first World Cell Race, finishing first with a cellular speed record of 5.2 microns per minute (or 0.000204 inches per minute) in results announced today at the 51st Annual Meeting of the American Society for Cell Biology (ASCB).
The mesenchymal bone marrow stem cells grown at the National University of Singapore by Yuchun Liu, PhD, were one of 70 cell lines entered by labs from all over the world and raced on specially designed micro-tracks, a few microns wide and 400 microns long. The micro-tracks, donated by CYTOO Cell Architects of Grenoble, France, were coated with fibronectin, a natural substrate on which the cells could get traction. The racing cell lines were frozen for shipment to one of six labs around the globe where they were thawed, stained with fluorescent dyes, and raced against the clock. The action was video recorded for 24 hours and the times were sorted by custom software created at the Institut Curie in Paris, according to Manuel Théry, PhD, who along with Ana-Maria Lennon-Duménil, PhD, and Matthieu Piel, PhD, organized the World Cell Race. Piel and Lennon-Duménil are at the Institut Curie. Théry is with the Institut de Recherche en Technologies et Sciences pour le Vivant (iRTSV) in Grenoble, France. The institute is part of the Commissariat à l'Energie Atomique (CEA).
"We measured the position and speeds of all individual cells in each group," says Théry. "For each cell line, we then determined the fastest run over 400 microns."
Théry says the idea for a cell race came to them at last year's ASCB Annual Meeting in Philadelphia where the three French scientists were struck by the large number of papers and the lively discussions about cell migration. How cells move is one of the hottest fields in research today because of the implications in cancer where motilitythe ability of tumor cells to move autonomously--is critical to understanding how cancer metastasizes. Cell movement is also vital to normal biology including embryonic development and human growth. Théry says that the World Cell Race was a way to mix the fun of a scientific sporting event with serious research into how speed reflects the nature of certain cells.
Finishing second and third place were cell lines provided by Odile Filhol-Cochet, PhD, of iRTSV/CEA in France. The second place winners were "wild type" normal mammary breast epithelial cells, clocked along the 400 micron track at 3.2 microns per minute. Third place award went to a cell culture of these mammary epithelial cells altered in the lab with a knocked-down casein kinase 2 and an overactive Ras pathway. The re-engineered cells roared down the track at 2.7 microns per minute.
In fourth place were human keratinocytes cultured from samples taken from patients suffering from Kindler syndrome, a rare genetic skin disorder, entered by Rumena Begum of King's College London, UK. Their speed over 400 microns was 2.5 microns per minute.
The winners will receive a Nikon camera and a World Cell Race medal.
In addition to being enjoyable, the first World Cell Race generated valuable data. "Data analysis revealed an unknown feature of cell migration," says Théry. "Fast cells were persistent⎯they rarely changed the direction of their migration. Slow cells were not persistent. They went back and forth." Correlating the speed of cells to their invasive behavior in cancer, for example, could uncover new approaches to treatment, Théry believes.
If the First World Cell Race is a success at ASCB, Théry hopes for a second running next year. "Maybe with additional games," he suggests. "Swimming and weightlifting."
More information: http://www.ascb.or … bgroup.cfm#i
Provided by American Society for Cell Biology
-
A recent IRCM breakthrough impacts cancer research
Oct 28, 2010 |
not rated yet |
0
-
Disappearance of genetic material allows tumor cells to grow
Aug 04, 2011 |
not rated yet |
0
-
Study identifies gene involved in blood stem cell replication, movement
Apr 09, 2008 |
not rated yet |
0
-
New role for Vascular Endothelial Growth Factor in regulating skin cancer stem cells
Oct 19, 2011 |
not rated yet |
0
-
Stem cell research to benefit horse owners and trainers
Oct 21, 2008 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Potential Breakthrough in Seizure Control
13 hours ago
-
Popping/Cracked sternum.
18 hours ago
-
Which Mental Illness Encompasses This Problem?
18 hours ago
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
- More from Physics Forums - Medical Sciences
More news stories
Skp2 activates cancer-promoting, glucose-processing Akt
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
Cancer
May 25, 2012 |
not rated yet |
0
|
Pancreatectomy OK without downstaging from therapy
(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published ...
Cancer
May 25, 2012 |
not rated yet |
0
Common therapies for basal cell carcinoma offer similar survival
(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published ...
Cancer
May 25, 2012 |
not rated yet |
0
Cancer may require simpler genetic mutations than previously thought
Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...
Cancer
May 25, 2012 |
not rated yet |
0
|
New prostate cancer screening guidelines face a tough sell, study suggests
(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter ...
Cancer
May 25, 2012 |
not rated yet |
1
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Weight struggles? Blame new neurons in your hypothalamus
New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.